Skip to main content
. 2023 Jun 10;15:100510. doi: 10.1016/j.ajpc.2023.100510

Fig. 1.

Fig 1

Proportion of participants eligible for IPE treatment. (A) A schematic outlining population from EMPA-REG OUTCOME eligible for IPE treatment fulfilling REDUCE-IT-like criteria. (B) A schematic outlining population from EMPA-REG OUTCOME eligible for IPE treatment fulfilling FDA label criteria. Abbreviations: FDA, Food and Drug Administration; LDL-C, low-density lipoprotein cholesterol.